[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Knee Osteoarthritis Market [By Treatment – Non-Surgical Treatment (NSAIDS, Corticosteroids, Hyaluronic Acid Injections & Alternate Therapies) & Surgical Treatment; By Region – North America, Europe & Asia Pacific] Outlook 2025

July 2019 | 72 pages | ID: GA36F1624B8EN
Rockville Research

US$ 1,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Rise in R&D activities in global knee osteoarthritis treatment industry has led to identification of promising options such as use of stem cells for treatment of knee osteoarthritis. Mesenchymal stromal cells (MSCs) is found to have potential to regenerate knee cartilage, thereby, substantially reducing pain in knee osteoarthritis patients.

The report “Global Knee Osteoarthritis Market [By Treatment – Non-Surgical Treatment (NSAIDS, Corticosteroids, Hyaluronic Acid Injections & Alternate Therapies) & Surgical Treatment; By Region – North America, Europe & Asia Pacific] Outlook 2025” provides an in-depth analysis of global knee osteoarthritis market with focus on various therapeutics such NSAIDS, Corticosteroids and Hyaluronic Acid Injections. Geographical analysis is done across leading markets in regions such as North America, Europe & Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global knee osteoarthritis market. The report has been segmented as following:-

Geographical Coverage
  • North America - The US
  • Europe
  • Asia Pacific
Key Vendors
  • Anika Therapeutics, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • DePuy Synthes (Johnson& Johnson)
1. EXECUTIVE SUMMARY

2. RESEARCH METHODOLOGY

3. OSTEOARTHRITIS

3.1 Overview
  3.1.1 Symptoms
  3.1.2 Risk Factors
3.2 Stages
3.3 Diagnosis & Treatment
  3.3.1 Diagnosis
  3.3.2 Treatment

4. MARKET ANALYSIS

4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
  4.2.1 Market Share by Drugs
  4.2.2 Market Share by Region

5. MARKET SEGMENTATION BY TREATMENT

5.1 Non-Surgical Treatment
  5.1.1 Non-Steroidal Anti-Inflammatory Drugs
    5.1.1.1 Market Sizing (Actual & Forecasted)
  5.1.2 Corticosteroids
    5.1.2.1 Market Sizing (Actual & Forecasted)
  5.1.3 Hyaluronic Acid Injections
    5.1.3.1 Market Sizing (Actual & Forecasted)
  5.1.4 Alternate Therapies
  5.1.5 Others
5.2 Surgical Treatment
  5.2.1 Overview
  5.2.2 Market Sizing (Actual & Forecasted)

6. REGIONAL ANALYSIS

6.1 North America
  6.1.1 Market Sizing (Actual & Forecasted)
6.2 Europe
  6.2.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
  6.3.1 Market Sizing (Actual & Forecasted)

7. MARKET DYNAMICS

7.1 Industry Trends & Developments
  7.1.1 Stem Cell Treatment for Osteoarthritis
  7.1.2 Use of Regenerative Medicine for Treatment
  7.1.3 Rise in Demand for MAKOplasty
  7.1.4 Disease Modifying Drugs
7.2 Growth Drivers
  7.2.1 Rising Geriatric Population
Figure 14: Prevalence of Osteoarthritis by Age & Sex, 2017-18
  7.2.2 Prevalence of Osteoarthritis Incidences
  7.2.3 Rise in Number of Obese Population
  7.2.4 Favorable Reimbursement Policies
7.3 Challenges
  7.3.1 Stringent Regulatory Compliance
  7.3.2 Side Effects of Treatment Procedures

8. COMPETITIVE LANDSCAPE

8.1 Financial Analysis
8.2 Products Portfolio

9. COMPANY PROFILES

9.1 Anika Therapeutics, Inc
9.2 Zimmer Biomet Holdings, Inc.
9.3 Stryker Corporation
9.4 DePuy Synthes (Johnson & Johnson)


More Publications